Biomedical Network Research Center on Rare Diseases (CIBERER), ISCIII, Alvaro de Bazán 10 bajo, 46010 Valencia, Spain.
Chembiochem. 2013 May 27;14(8):943-9. doi: 10.1002/cbic.201200708. Epub 2013 Apr 18.
New human β-glucocerebrosidase (GCase) ligands with rigid 1,6-anhydro-β-L-idonojirimycin cores have been designed with the aid of molecular modeling. Efficient pharmacological chaperones for the L444P (trafficking-incompetent) mutant GCase enzyme associated with type 2 and 3 Gaucher disease (GD) were identified.
新型人源β-葡糖脑苷脂酶(GCase)配体具有刚性 1,6-脱水-β-L-艾杜糖己腈核心,借助分子建模设计而成。鉴定出与 2 型和 3 型 Gaucher 病(GD)相关的 L444P(运输缺陷)突变 GCase 酶的有效药理学伴侣。